<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Personalized medicine, leave U.S. behind</title>
	<atom:link href="http://www.genomicslawreport.com/index.php/2009/10/07/personalized-medicine-leave-u-s-behind/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.genomicslawreport.com/index.php/2009/10/07/personalized-medicine-leave-u-s-behind/</link>
	<description>News and analysis from the intersection of genomics, personalized medicine and the law</description>
	<lastBuildDate>Tue, 07 Feb 2012 00:02:31 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
	<item>
		<title>By: medical blog</title>
		<link>http://www.genomicslawreport.com/index.php/2009/10/07/personalized-medicine-leave-u-s-behind/comment-page-1/#comment-11763</link>
		<dc:creator>medical blog</dc:creator>
		<pubDate>Wed, 29 Dec 2010 05:10:07 +0000</pubDate>
		<guid isPermaLink="false">http://www.genomicslawreport.com/?p=995#comment-11763</guid>
		<description>Genetic patents can really make a big difference too.  Genes should not be patented.</description>
		<content:encoded><![CDATA[<p>Genetic patents can really make a big difference too.  Genes should not be patented.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: David Jackemeyer</title>
		<link>http://www.genomicslawreport.com/index.php/2009/10/07/personalized-medicine-leave-u-s-behind/comment-page-1/#comment-839</link>
		<dc:creator>David Jackemeyer</dc:creator>
		<pubDate>Tue, 13 Oct 2009 20:09:26 +0000</pubDate>
		<guid isPermaLink="false">http://www.genomicslawreport.com/?p=995#comment-839</guid>
		<description>I am confused about the [insurance company - to - individual] relationship.  What I read above implies that the author sees an insurance company as merely another governmental medicare program.

With governments, citizens under jurisdiction (read: within scope of a weapon+amo) are coerced to provide 33% to 50% of personal production value.  As one becomes more valuable to hir fellow citizens, one contributes more, both in total amount and in percentage of hir production value, termed &quot;progressive taxation&quot;.  These resources, termed &quot;tax revenue&quot;, are then up for grabs to &quot;representatives&quot; of the citizens.  Medical programs are funded by 35% of this tax revenue, and regardless of one&#039;s actions, planning, genetics, accidents, abilities, risky behavior, ignorance, education, etc., each citizen is alloted any amount of coverage for hir injuries.  No need to ask who is responsible, what were the causes/associated actions, etc.
IMO, this is an example of great inefficiency.

With insurance companies, individuals seek to have the backing of a large financier in case unexpected life-threatening damage or changes occur.  The individual must develop a reputation for practicing good health in order to keep premiums low while the insurance companies develop a reputation for financing those unexpected repairs.
IMO, this is an example of greater efficiency.

Why do you (author) describe the insurance company as a governmental agency?

Thanks,
D Jackemeyer
Assistant Researcher
Tempe, AZ</description>
		<content:encoded><![CDATA[<p>I am confused about the [insurance company - to - individual] relationship.  What I read above implies that the author sees an insurance company as merely another governmental medicare program.</p>
<p>With governments, citizens under jurisdiction (read: within scope of a weapon+amo) are coerced to provide 33% to 50% of personal production value.  As one becomes more valuable to hir fellow citizens, one contributes more, both in total amount and in percentage of hir production value, termed &#8220;progressive taxation&#8221;.  These resources, termed &#8220;tax revenue&#8221;, are then up for grabs to &#8220;representatives&#8221; of the citizens.  Medical programs are funded by 35% of this tax revenue, and regardless of one&#8217;s actions, planning, genetics, accidents, abilities, risky behavior, ignorance, education, etc., each citizen is alloted any amount of coverage for hir injuries.  No need to ask who is responsible, what were the causes/associated actions, etc.<br />
IMO, this is an example of great inefficiency.</p>
<p>With insurance companies, individuals seek to have the backing of a large financier in case unexpected life-threatening damage or changes occur.  The individual must develop a reputation for practicing good health in order to keep premiums low while the insurance companies develop a reputation for financing those unexpected repairs.<br />
IMO, this is an example of greater efficiency.</p>
<p>Why do you (author) describe the insurance company as a governmental agency?</p>
<p>Thanks,<br />
D Jackemeyer<br />
Assistant Researcher<br />
Tempe, AZ</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Non-Competes, Health Insurance and Other Ugly Limits To Innovation &#124; Frog Blog</title>
		<link>http://www.genomicslawreport.com/index.php/2009/10/07/personalized-medicine-leave-u-s-behind/comment-page-1/#comment-768</link>
		<dc:creator>Non-Competes, Health Insurance and Other Ugly Limits To Innovation &#124; Frog Blog</dc:creator>
		<pubDate>Fri, 09 Oct 2009 10:41:54 +0000</pubDate>
		<guid isPermaLink="false">http://www.genomicslawreport.com/?p=995#comment-768</guid>
		<description>[...]  [...]</description>
		<content:encoded><![CDATA[<p>[...]  [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: PolITiGenomics &#187; Blog Archive &#187; What ELSI is New?</title>
		<link>http://www.genomicslawreport.com/index.php/2009/10/07/personalized-medicine-leave-u-s-behind/comment-page-1/#comment-750</link>
		<dc:creator>PolITiGenomics &#187; Blog Archive &#187; What ELSI is New?</dc:creator>
		<pubDate>Wed, 07 Oct 2009 14:09:09 +0000</pubDate>
		<guid isPermaLink="false">http://www.genomicslawreport.com/?p=995#comment-750</guid>
		<description>[...] contribution to the Genomics Law Report&#8217;s What ELSI is New? series appears today, Personalized medicine, leave U.S. behind. The piece discusses the challenges our current health care system presents to genetic research and [...]</description>
		<content:encoded><![CDATA[<p>[...] contribution to the Genomics Law Report&#8217;s What ELSI is New? series appears today, Personalized medicine, leave U.S. behind. The piece discusses the challenges our current health care system presents to genetic research and [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>

